Pentamidine uptake and resistance in pathogenic protozoa: past, present and future

被引:195
作者
Bray, PG
Barrett, MP
Ward, SA
de Koning, HP [1 ]
机构
[1] Univ Glasgow, Inst Biomed & Life Sci, Div Infect & Immun, Glasgow G12 8QQ, Lanark, Scotland
[2] Univ Liverpool Liverpool Sch Trop Med, Mol & Biochem Parasitol Grp, Liverpool L3 5QS, Merseyside, England
基金
英国惠康基金;
关键词
D O I
10.1016/S1471-4922(03)00069-2
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
Diamidines, and pentamidine in particular, have a long history as valuable chemotherapeutic agents against infectious disease. Their selectivity is due mostly to selective accumulation by the pathogen, rather than the host cell; and acquired resistance is frequently the result of changes in transmembrane transport of the drug. Here, recent progress in elucidating the mechanisms of diamidine transport in three important protozoan pathogens, Trypanosoma brucei, Leishmania and Plasmodium falciparum, is reviewed, and the implications for drug resistance are discussed.
引用
收藏
页码:232 / 239
页数:8
相关论文
共 70 条
[1]   The biochemical basis of arsenical-diamidine crossresistance in African trypanosomes [J].
Barrett, MP ;
Fairlamb, AH .
PARASITOLOGY TODAY, 1999, 15 (04) :136-140
[2]   Alterations in membrane fluidity, lipid metabolism, mitochondrial activity, and lipophosphoglycan expression in pentamidine-resistant Leishmania [J].
Robert-Gero M. .
Parasitology Research, 1997, 84 (1) :78-83
[3]   Putrescine and spermidine transport in Leishmania [J].
Basselin, M ;
Coombs, GH ;
Barrett, MP .
MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 2000, 109 (01) :37-46
[4]   Effects of pentamidine on polyamine level and biosynthesis in wild-type, pentamidine-treated, and pentamidine-resistant Leishmania [J].
Basselin, M ;
BadetDenisot, MA ;
Lawrence, F ;
RobertGero, M .
EXPERIMENTAL PARASITOLOGY, 1997, 85 (03) :274-282
[5]   Resistance to pentamidine in Leishmania mexicana involves exclusion of the drug from the mitochondrion [J].
Basselin, M ;
Denise, H ;
Coombs, GH ;
Barrett, MP .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (12) :3731-3738
[6]   Modification of kinetoplast DNA minicircle composition in pentamidine-resistant Leishmania [J].
Basselin, M ;
Badet-Denisot, MA ;
Robert-Gero, M .
ACTA TROPICA, 1998, 70 (01) :43-61
[7]   Altered transport properties of pentamidine-resistant Leishmania donovani and L-amazonensis promastigotes [J].
Basselin, M ;
Lawrence, F ;
RobertGero, M .
PARASITOLOGY RESEARCH, 1997, 83 (05) :413-418
[8]   The efficacy of pentamidine combined with allopurinol and immunotherapy for the treatment of patients with diffuse cutaneous leishmaniasis [J].
Becker, I ;
Volkow, P ;
Velasco-Castrejon, O ;
Salaiza-Suazo, N ;
Berzunza-Cruz, M ;
Dominguez, JSD ;
Morales-Vargas, A ;
Ruiz-Remigio, A ;
Perez-Montfort, R .
PARASITOLOGY RESEARCH, 1999, 85 (03) :165-170
[9]   STRUCTURE-ACTIVITY-RELATIONSHIPS OF ANALOGS OF PENTAMIDINE AGAINST PLASMODIUM-FALCIPARUM AND LEISHMANIA-MEXICANA-AMAZONENSIS [J].
BELL, CA ;
HALL, JE ;
KYLE, DE ;
GROGL, M ;
OHEMENG, KA ;
ALLEN, MA ;
TIDWELL, RR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (07) :1381-1386
[10]   CHARACTERIZATION OF PENTAMIDINE-RESISTANT TRYPANOSOMA-BRUCEI-BRUCEI [J].
BERGER, BJ ;
CARTER, NS ;
FAIRLAMB, AH .
MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 1995, 69 (02) :289-298